 Your new post is loading...
Your new post is loading...
|
Scooped by
Gilbert C FAURE
January 4, 2012 4:00 AM
|
Mucosal immunity against pathogens involves the production of secretory IgA (sIgA) and the generation of T cell immunity against the pathogen (Wickens et al., 2008). IL-17 production by T helper 17 (Th17) cells has recently ...
|
|
Scooped by
Gilbert C FAURE
January 4, 2012 4:00 AM
|
IgA Nephropathy is a kind of glomerular disease which has features of mesangial proliferation and prominent sedimentation of IgA in the mesangial area, IgA Nephropathy is common in kids and youngsters, the number of ...
|
|
Scooped by
Gilbert C FAURE
January 4, 2012 3:58 AM
|
Scientific American (blog)Your Appendix Could Save Your LifeScientific American (blog)2002 Jun 15;73(11):1717-23 3-Bollinger RR, Everett ML, Wahl SD, Lee YH, Orndorff PE, Parker W.
|
|
Scooped by
Gilbert C FAURE
December 31, 2011 7:07 PM
|
All about feedMinimising antibiotic use with integrated gut management approachAll about feed... resulting in translocation of bacteria; and has shorter villi.
|
|
Scooped by
Gilbert C FAURE
December 31, 2011 8:50 AM
|
The company's technology has demonstrated numerous potential advantages over traditional vaccines, including: the ability to generate robust mucosal, systemic and cellular immunity; antigen-sparing qualities; ...
|
|
Scooped by
Gilbert C FAURE
December 29, 2011 11:34 AM
|
NanoBio(R) to Collaborate in Research Effort for Respiratory Syncytial Virus ...MarketWatch (press release)The company's technology has demonstrated numerous potential advantages over traditional vaccines, including: the ability to generate robust...
|
|
Scooped by
Gilbert C FAURE
December 29, 2011 10:26 AM
|
Human Trials Initiated for New HIV VaccinePR Newswire (press release)Our collaboration marks an important juncture for the field as we begin to assess which routes of immunization may provide the best responses to protect women," remarked Professor...
|
|
Scooped by
Gilbert C FAURE
December 29, 2011 10:25 AM
|
Immunity . 2011 Dec 23; 35(6): 997-1009 Chen K, McAleer JP, Lin Y, Paterson DL, Zheng M, Alcorn JF, Weaver CT, Kolls JK The interleukin-17 (IL-17) family of cytokines phylogenetically predates the evolution of T cells in ...
|
|
|
Scooped by
Gilbert C FAURE
January 4, 2012 4:00 AM
|
In the December 2011 issue of American Journal of Kidney Diseases, Jurgen Floege discusses the novel development of pathogenesis of IgA Nephropathy. Test your knowledge with a word search. Clues to the answers are ...
|
|
Scooped by
Gilbert C FAURE
January 4, 2012 3:59 AM
|
Post-doctoral positionScientific AmericanThis is associated with an abnormal transepithelial transport in secretory epithelia and chronic inflammation.
|
|
Scooped by
Gilbert C FAURE
January 2, 2012 6:34 AM
|
Nanotechnology-based drug delivery in mucosal immune diseases: hype or hope? – Nature.com. December 31 2011 by Nanoparticles in Info & Articles |No Comments. The operate of nanotechnology (i.e., a strategy as good as lift out of ...
|
|
Scooped by
Gilbert C FAURE
December 31, 2011 8:51 AM
|
In recent years, Toxoplasma gondii's vaccine has made great progress from the earliest dead vaccine to the late nucleic acid vaccine. Especially compound polyvalent vaccine and nucleic acid vaccine bring about new vitality and hope for ...
|
|
Scooped by
Gilbert C FAURE
December 29, 2011 11:34 AM
|
Peptides corresponding to the foot-and-mouth disease virus VP1 G-H loop are capable of inducing neutralizing antibodies in some species but are considered relatively poor immunogens, especially at mucosal surfaces.
|
|
Scooped by
Gilbert C FAURE
December 29, 2011 10:31 AM
|
Clinical Implications of Basic Research from The New England Journal of Medicine — Eliciting Mucosal Immunity.
|
|
Scooped by
Gilbert C FAURE
December 29, 2011 10:26 AM
|
3rd TNO Beneficial Microbes ConferenceNature.comFor probiotics, an interaction with the mucosal immune system seems the major mechanism by which these beneficial microbes exert their benefit to the host.
|
|
Scooped by
Gilbert C FAURE
December 29, 2011 10:25 AM
|
University of York to take part in HIV vaccine trialsThe Press, YorkProfessor Charles Lacey will lead the study at York, working with Dr Catherine Cosgrove at St George's and Professor Robin Shattock, chair of mucosal infection and immunity at...
|
Scoop.it!
